Statistics for X4 Pharmaceuticals (id:5511 XFOR)
Valuation metrics
Market cap
99.77M
Enterprise value
21.22M
Trailing P/E (ttm)
4.55
Forward P/E
-1.26
PEG ratio
-1.26
Price/Sales (ttm)
177.21
Price/Book (mrq)
1.05
Enterprise Value/Revenue
37.70
Enterprise Value/EBITDA
-0.17
Overview
Shares outstanding
168.50M
Float
127.83M
Shares short
12.66M
% Held by insiders
0.01%
% Held by institutions
0.67%
Average volume (10 days)
1.61M
Average volume (90 days)
Price summary
52-Week low
0.26
52-Week high
1.60
52-Week change
-136.98%
Beta
0.39
50-Day moving average
0.60
200-Day moving average
0.86
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
March 14th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
March 14th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
3.13K%
Operating margin
-6,020.78%
Operational effectiveness
Return on assets
-40.23%
Return on equity
21.77%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-123,177,000.00
Net income to common (ttm)
17.63M
Diluted EPS (ttm)
0.13
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
168.75M
Total cash per share (mrq)
1.00
Total debt (mrq)
78.23M
Total Debt/Equity (mrq)
82.82
Current ratio (mrq)
606.90%
Book value per share (mrq)
0.56
Cash flow
Cash flow statement
-112,449,000.00
Levered free cash flow (LFCF)
-71,706,624.00